Role of Senescent Cells in Uterine Fibroid Pathogenesis (SOUL Study)

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-55
SponsorJohns Hopkins University

About this trial

The investigators are evaluating the role of senescent cells in uterine fibroids.

Eligibility criteria

Qualifiers

Subjects must be women above the age of ≥18 - ≤55 years.

Women with suspected uterine fibroids.

Subject must be or have been sexually active or have had a previous vaginal exam that used a speculum.

Subject must be able to understand, read and speak English or Spanish and subsequently, be able to understand what she is consenting to in terms of procedures and use/disclosure of protected health information.

Disqualifiers

Unwilling to sign the consent form or complete questionnaire.

Pregnancy.

Cancer of the uterus

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

150 Participants
are grouped into 1 trial group

Locations

1
Johns Hopkins Hospital21287, BaltimoreMaryland, United States

Sponsors and collaborators

Johns Hopkins University

Lead sponsor

National Institutes of Health (NIH)

Collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Collaborator